Family offices
London family-office principals with US-bound portfolio companies, US co-investment, or direct US platform-building. Non-dom-reform-driven re-sequencing often surfaces here first.
Family offices in London →
US market architecture for family offices, private-client fiduciaries, and operators headquartered in London. British understatement reads as dry in America. Non-dom reform is rerouting capital. The US-facing story has to keep up.
The London business is real. Standing in the Mayfair family-office belt, the City of London financial ring, or the London cyber and medtech clusters has been earned through years of delivery, regulatory posture, and quiet compounding. Revenue is validated. The decision is made to put weight into the US market, or the non-dom reform has forced a re-sequencing that puts the US on the table earlier than planned. A US subsidiary opens, a US acquisition closes, a US co-investment runs, or a portfolio company begins its American commercialisation. The first ninety days do not match the model. US meetings happen. US follow-up goes cold.
The instinct is to assume that because both markets operate in English, the same materials will land. The instinct is wrong. British commercial culture signals seriousness through restraint, context, and understatement. American commercial culture reads the same restraint as dry, distant, or underclaimed. The category anchor the American buyer is scanning for is typically implicit in London materials and invisible to the US reader.
Two additional forces are live in 2025 and 2026. First, the non-dom reform has rerouted capital flows. Family offices are reworking holding-brand materials for new jurisdictional postures, and US co-investment vehicles are moving up the priority list. Second, US scrutiny of UK origin is higher than it was five years ago. The US-facing surface has to do more work than it used to.
Translation is not the fix. The words already work. The frame around them does not. House view on London to US entry
The register is not the problem at home. It is the entire problem at the border.
London family-office principals with US-bound portfolio companies, US co-investment, or direct US platform-building. Non-dom-reform-driven re-sequencing often surfaces here first.
Family offices in London →London-headquartered CEOs and commercial leaders running a US subsidiary, closing a US acquisition, or entering US markets directly. Cyber, medtech, biotech, technical B2B, engineering-commercial.
Operators in London →London solicitors, tax advisors, trust officers, and family-office principals introducing international clients to US engagements. Revenue-neutral, confidential, commission-free.
Fiduciaries in London →Six to ten weeks. Single US category, single corridor. The firm rebuilds positioning, pricing posture, messaging, and trust architecture for the American buyer, then launches it into market.
See the Sprint →Three to six months. Multi-channel US rebuild and run. Paid, owned, earned, conversion architecture, and sales enablement. The standard shape for London principals committed to US scale.
See the Build →Monthly retainer, twelve-month minimum. Ongoing rebuild-and-run across multiple US surfaces. Typical for London family offices and fiduciary-introduced portfolios with several US-facing brands or holdings.
See the Partnership →No legal services. No UK company formation or US entity formation. No FCA authorisation, L-1, E-2, EB-5, or O-1 visa work. No non-dom transitional advice, US tax structuring, FATCA analysis, or double-tax-treaty review. No US banking introductions. No fiduciary services. No regulatory licensing. No IP filing. No contract drafting.
These belong with UK counsel who specialise in US entry, and with US counsel on the American side. The firm works inside the parameters they set. When a marketing decision carries legal or tax implications, the firm flags it and defers before execution.
Shared language hides the register gap. British English is tighter, more understated, and more context-dependent. American buyers read the same material as dry, distant, or underclaimed. The category anchor and outcome claim the US buyer filters on are typically implicit in London materials and invisible to the American reader. The product is the same. The frame around it does not carry across the Atlantic. The correction is not translation. It is register rebuild.
The 2025 non-dom reform is accelerating two flows. First, outflow of capital and residency from the UK toward Dubai, Singapore, Switzerland, and the US. Second, US-bound activity from UK-based operators and holding structures whose tax position has changed. The US-facing commercial story has to keep up with the new posture. Family offices are rebuilding holding-brand materials. Operators are re-sequencing US entry. Fiduciaries are managing cross-border transitions where the American side of the capital flow needs a commercial frame.
Cyber, medtech, biotech, technical B2B, engineering-commercial firms, and family-office-backed holdings. The firm also works with London-based private-client fiduciaries introducing international principals to US operators, and with UK operators whose US subsidiary or US acquisition needs commercial architecture. Fit is confirmed in discovery, not in published sector lists.
No. UK company formation, FCA authorisation, US LLC or C-corp formation, L-1, E-2, EB-5, and O-1 visa support, transfer pricing, non-dom transitional advice, US tax residency, and US banking introductions are handled by the principal's UK counsel and US counsel. The firm designs US marketing architecture inside the structure counsel has already put in place.
No. The firm does not pay referral commissions to London solicitors, tax advisors, trust officers, or family offices who introduce principals. Introductions are revenue-neutral. The fiduciary retains the relationship with the principal. The firm delivers the US-facing work inside the structure the fiduciary already manages. Fiduciary introductions route through partnerships@globalmarketing.agency.
With an inquiry through the contact form and a short discovery conversation. The firm runs three engagements: Market Entry Sprint (6 to 10 weeks), Cross-Border Build (3 to 6 months), or Group Partnership (monthly retainer, 12-month minimum). Fit and pricing are confirmed in discovery, not published.
How family offices and operators are re-sequencing US activity under the 2025 non-dom reform and what the American-facing story needs to carry.
Read the piece →Why UK cyber and medtech credibility does not carry to US federal and commercial buyers, and what to rebuild first.
Read the piece →The wider UK and Ireland gate for operators outside London.
See the UK/IE gate →